Email this article Pazopanib v lechenii rasprostranennogo pochechno-kletochnogo raka (klinicheskiy sluchay)
- Authors: Savkov RV1
-
Affiliations:
- ГУЗ Московский областной онкологический диспансер
- Issue: Vol 14, No 3 (2012)
- Pages: 16-19
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/29496
- ID: 29496
Cite item
Full Text
Abstract
About the authors
R V Savkov
ГУЗ Московский областной онкологический диспансерГУЗ Московский областной онкологический диспансер
References
- Bernard J Escudier, Camillo Porta, Petri Bono et al. Patient preference between pazopanib (Paz) and sunitinib (Sun): Results of a randomized double-blind, placebo-controlled, cross-over study in patients with metastatic renal cell carcinoma (mRCC)-PISCES study, NCT 01064310. J Clin Oncol (Suppl; abstr CRA4502); 2012.
